4599StemRIM4599 info
$2.12info-5.54%24h
Global rank17823
Market cap$127.56M
Change 7d-4.71%
YTD Performance-44.14%
SP500 benchmarkUnderperform
P/E0.79
P/S8.28
Revenue$15.41M
Earnings$1.10M
Dividend yield-
Main Sector
Healthcare

StemRIM (4599) Stock Overview

StemRIM, a biotechnology company, develops regeneration medicines for the treatment of intractable diseases. The company develops PJ1, a regeneration induction medicine HMGB1 peptides, which is in Phase II clinical trials for the treatment of epidermolysis bullosa, cerebral infarction, osteoarthritis, and chronic liver disease, as well as cardiomyopathy. Its pre-clinical stage products include PJ2 and PJ3 to treat multiple tissue damage disease; PJ4, an autologous cell sampling device for medical treatment; and PJ5, a stem cell gene therapy. StemRIM was incorporated in 2006 and is based in Ibaraki, Japan.

4599 Stock Information

Symbol
4599
Address
Saito Bio-IncubatorIbaraki, 567-0085Japan
Founded
-
Trading hours
-
Website
https://www.stemrim.com
Country
🇯🇵 Japan
Phone Number
81 72 648 7152

StemRIM (4599) Price Chart

-
Value:-

StemRIM Overview: Key Details and Summary

Stock data
2023
Change
Price
$2.12
N/A
Market Cap
$127.56M
N/A
Shares Outstanding
60.06M
1.46%
Employees
45.00
N/A
Shareholder Equity
10.37B
10.27%
Valuation
2023
Change
P/E Ratio
0.79
N/A
P/S Ratio
8.28
N/A
P/B Ratio
0.01
N/A
Growth
2023
Change
Return on Equity
0.0001
N/A
Earnings
2023
Change
Revenue
$15.41M
N/A
Earnings
$1.10M
N/A
EPS
2.69
N/A
Earnings Yield
1.27
N/A
Operating Margin
0.0606
N/A
Net income margin
0.0716
N/A
Financial Strength
2023
Change
Total Assets
$70.19M
N/A
Total Debt
$3.48K
N/A
Cash on Hand
$66.99M
N/A
Debt to Equity
0.0002
58.36%
Cash to Debt
$19.24K
695.69%
Current Ratio
$47.99
-62.79%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org